Capricor Therapeutics
CAPR
#7367
Rank
โ‚ฌ0.50 B
Marketcap
8,64ย โ‚ฌ
Share price
-6.93%
Change (1 day)
76.62%
Change (1 year)

EPS for Capricor Therapeutics (CAPR)

EPS in 2026 (TTM): -2,11ย โ‚ฌ

According to Capricor Therapeutics 's latest financial reports the company's current EPS (TTM) is -2,22ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -2,05ย โ‚ฌ a decrease over its 2024 EPS that were of -1,09ย โ‚ฌ.

EPS history for Capricor Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-2,11ย โ‚ฌ2.98%
2025-2,05ย โ‚ฌ88.33%
2024-1,09ย โ‚ฌ
2022-1,07ย โ‚ฌ35.63%
2021-0,79ย โ‚ฌ-7.45%
2020-0,85ย โ‚ฌ-55.45%
2019-1,91ย โ‚ฌ-59.81%
2018-4,76ย โ‚ฌ-1850%
20170,27ย โ‚ฌ-102.94%
2016-9,25ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
6,06ย โ‚ฌ-372.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
6,32ย โ‚ฌ-384.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-5,48ย โ‚ฌ 146.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-3,95ย โ‚ฌ 77.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-6,85ย โ‚ฌ 208.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-26,57ย โ‚ฌ 1,095.51%๐Ÿ‡บ๐Ÿ‡ธ USA